Anthony Ting
Corporate Officer/Principal chez International Society For Cell & Gene Therapy
Profil
Anthony Ting is currently the Chief Commercialization Officer at the International Society for Cell & Gene Therapy.
Previously, he worked as the Chief Scientific Officer at Bone Therapeutics SA. He received his undergraduate degree from Amherst College and his doctorate from The Johns Hopkins University.
Postes actifs de Anthony Ting
| Sociétés | Poste | Début |
|---|---|---|
| International Society For Cell & Gene Therapy | Corporate Officer/Principal | - |
Anciens postes connus de Anthony Ting
| Sociétés | Poste | Fin |
|---|---|---|
| BIOSENIC SA | Chief Tech/Sci/R&D Officer | - |
Formation de Anthony Ting
| Amherst College | Undergraduate Degree |
| The Johns Hopkins University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Bone Therapeutics SA
 Bone Therapeutics SA Pharmaceuticals: MajorHealth Technology Bone Therapeutics SA is a cell therapy company, which engages in the regenerative therapy addressing for unmet medical needs in the field of bone diseases and orthopedics. Its products include Allob and JTA-004. The company was founded by Jacques Reymann on June 16, 2006 and is headquartered in Gosselies, Belgium. | Health Technology |
| International Society For Cell & Gene Therapy |
